Researchers say the introduction of typhoid conjugate vaccines in these countries could help protect communities, especially school-aged children.
A literature review found pneumococcal conjugate vaccines were associated with some protection against flu and other viral respiratory tract infections.
The experimental vaccine is currently being evaluated in a phase 3 clinical trial in patients aged 60 years and older.
The funding will help the Bacterial Vaccines Network diversify its pipeline of bacterial vaccine development projects.
One study found hospitalization was lower among older adults who received the vaccine, while another found significant racial and socioeconomic disparities in vaccine uptake.
The results of a phase 2 trial show the experimental vaccine, when given to pregnant women, substantially reduced the risk of group B streptococcus infection in their infants.
A roundup of infectious disease stories in the news.
ACIP topics include RSV, flu, polio, mpox, meningococcal, and COVID-19 vaccines.
The biggest declines in the belief "Vaccines are important for children" occurred in the DR Congo (20% decline), followed by Uganda (14%) and Nigeria (10.5%).
The approval gives the nation two RSV vaccine options for use in adults 60 and older.